This site is intended for health professionals only

Eight in 10 asthma sufferers have never had consultation about psychological effects of the condition, finds survey

Eight in ten adults (81%) with a diagnosis of asthma have never had a discussion with their healthcare professional about the psychological impact of the condition, a survey has found. The survey of 500 asthma suffers, carried out by Opinion Health, also found that while 46% of respondents would value psychological support, almost a quarter…
Read more

Respiratory service: ‘Pharmacists really do have a pivotal role to play in asthma care’

Name of pharmacy: Cadham Pharmacy, Glenrothes, Scotland. Name of pharmacist: Bernadette Brown. Why did you start offering the service? I’ve been offering the service since I opened up Cadham Pharmacy seven years ago, but I have been really specialising in respiratory for the past five years. I believed that there was a real need for…
Read more

Changes to inhaled asthma treatment

How do I go about changing people’s inhaled treatment if there are stock shortages? Pharmacist and Primary Care Respiratory Society (PCRS) executive committee member Darush Attar-Zadeh gives advice on asthma-related pharmacy queries during the coronavirus pandemic. We have seen some significant respiratory device shortages during the Covid-19 emergency period, and it may sometimes be necessary…
Read more

Considerations for switching asthma inhaler devices

What support should be offered to patients if their asthma device needs to be changed? Pharmacist and Primary Care Respiratory Society (PCRS) executive committee member Darush Attar-Zadeh gives advice for asthma-related pharmacy queries during the coronavirus pandemic. The virtual asthma review and the New Medicine Service (NMS) offer the ideal opportunity for pharmacists to find…
Read more

Covid-19: Asthma, hayfever, smoking cessation and rescue packs

Advice on common questions being asked during the Covid-19 pandemic Pharmacist and Primary Care Respiratory Society (PCRS) executive committee member Darush Attar-Zadeh gives advice for asthma-related pharmacy queries during the coronavirus pandemic. Q. Could a patient’s hayfever (allergic rhinitis) or smokers nicotine withdrawal symptoms be mistaken for Covid-19? Fever is a common symptom in Covid-19,…
Read more

Inhaled corticosteroids (ICS) use in asthma

Steps to take when you suspect a patient is under-using ICS Pharmacist and Primary Care Respiratory Society (PCRS) executive committee member Darush Attar-Zadeh gives advice for asthma-related pharmacy queries during the coronavirus pandemic. As Professor Anna Murphy, consultant respiratory pharmacist at University Hospitals of Leicester NHS Trust, says of ICS in asthma, this is: ‘The…
Read more

Asthma inhaler variant available soon to address increased demand

A variation of the regular Clenil 100mcg (beclometasone) asthma inhaler will soon be available for dispensing in the UK to help keep up with increased demand for the medication. Pharmaceutical company Chiesi has produced the new batch-specific inhaler which was recently approved by Medicines and Healthcare products Regulatory Agency (MHRA). The first batches will be available…
Read more

Asthma inhaler stock supply issues continue amid Covid-19 demand surge

Asthma inhalers continue to be out of stock at some wholesalers because of ‘a dramatic increase’ in demand for the medicine as a result of the Covid-19 pandemic. Manufacturers are struggling to replenish their wholesalers with new asthma inhalers quickly enough, which is causing the delays in stock. But the Government has stressed suppliers are…
Read more

Study: Asthma deaths linked to national financial inequality, not overall wealth

Gaps between the rich and poor are linked to an increase in asthma deaths, an international study of 32 countries has said. The research, presented at the British Thoracic Society Winter Meeting today (5 December), suggests that financial inequality at a national level is far more significant than the wealth of a country. There is…
Read more

NICE rethinks position on inhaled steroid doses in children with asthma

There is no evidence for increasing inhaled corticosteroid (ICS) doses in children experiencing asthma exacerbations, NICE has said in a draft update of its asthma guidance in a reversal of its previous position. The update removes the 2017 recommendation to consider quadrupling the regular dose of ICS in children who experience a deterioration, as there…
Read more